A phase II randomised trial comparing the cisplatin–etoposide combination chemotherapy with or without carboplatin as second-line therapy for small-cell lung cancer-Reference-Cited by-同舟云学术

A phase II randomised trial comparing the cisplatin–etoposide combination chemotherapy with or without carboplatin as second-line therapy for small-cell lung cancer

Published:2002-09 Issue:9 Volume:13 Page:1454-1459
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Sculier J.P.,Lafitte J.J.,Lecomte J.,Berghmans T.,Thiriaux J.,Van Cutsem O.,Efremidis A.,Ninane V.,Paesmans M.,Mommen P.,Klastersky J.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/13/9/1454/417103/mdf244.pdf

Reference22 articles.

1. Pneumologie;Sculier,2001

2. Second-line chemotherapy and its evaluation in small cell lung cancer;Huisman;Cancer Treat Rev,1999

3. Etoposide (VP-16) and cisplatin: an effective treatment for relapse in small-cell lung cancer;Evans;J Clin Oncol,1985

4. VP-16 alone and in combination with cisplatin in previously treated patients with small cell lung cancer;Evans;Cancer,1984

5. Cyclophosphamide, doxorubicin, and vincristine in etoposide- and cisplatin-resistant small cell lung cancer;Shepherd;Cancer Treat Rep,1987

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indirect comparison of nivolumab ± ipilimumab (CheckMate 032) versus other treatments for recurrent small-cell lung cancer;Journal of Comparative Effectiveness Research;2019-07

2. Prognostic effect of neuroendocrine differentiation in prostate cancer: A critical review;Urologic Oncology: Seminars and Original Investigations;2015-06

3. Treatment of Small Cell Lung Cancer;Chest;2013-05

4. The role of anthracyclines in small cell lung cancer;ANN TRANSL MED;2013

5. A Systematic Analysis of Efficacy of Second-Line Chemotherapy in Sensitive and Refractory Small-Cell Lung Cancer;Journal of Thoracic Oncology;2012-05